The stock of Tenax Therapeutics Inc (NASDAQ: TENX) has decreased by -10.86 when compared to last closing price of 4.05. Despite this, the company has experienced a 23.63% gain in its stock price over the last five trading sessions. investorplace.com reported 2024-08-06 that Tenax Therapeutics (NASDAQ: TENX ) stock is soaring higher on Tuesday after the company announced the completion of an oversubscribed private placement for its shares. This oversubscribed private placement has Tenax Therapeutics expecting $100 million in gross proceeds.
Is It Worth Investing in Tenax Therapeutics Inc (NASDAQ: TENX) Right Now?
The stock has a 36-month beta value of 2.11. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TENX is 1.88M, and at present, short sellers hold a 0.55% of that float. On August 13, 2024, the average trading volume of TENX was 496.52K shares.
TENX’s Market Performance
The stock of Tenax Therapeutics Inc (TENX) has seen a 23.63% increase in the past week, with a 7.98% rise in the past month, and a 0.70% gain in the past quarter. The volatility ratio for the week is 22.57%, and the volatility levels for the past 30 days are at 9.27% for TENX. The simple moving average for the last 20 days is 4.50% for TENX stock, with a simple moving average of -62.45% for the last 200 days.
Analysts’ Opinion of TENX
MLV & Co, on the other hand, stated in their research note that they expect to see TENX reach a price target of $7. The rating they have provided for TENX stocks is “Buy” according to the report published on December 16th, 2014.
WallachBeth gave a rating of “Buy” to TENX, setting the target price at $12 in the report published on November 18th of the previous year.
TENX Trading at 8.50% from the 50-Day Moving Average
After a stumble in the market that brought TENX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.10% of loss for the given period.
Volatility was left at 9.27%, however, over the last 30 days, the volatility rate increased by 22.57%, as shares surge +7.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.14% upper at present.
During the last 5 trading sessions, TENX rose by +23.63%, which changed the moving average for the period of 200-days by -83.90% in comparison to the 20-day moving average, which settled at $3.47. In addition, Tenax Therapeutics Inc saw -83.57% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TENX
Current profitability levels for the company are sitting at:
- 658.28 for the present operating margin
- -0.15 for the gross margin
The net margin for Tenax Therapeutics Inc stands at -432.65. The total capital return value is set at 0.31. Equity return is now at value -75.66, with -67.96 for asset returns.
Based on Tenax Therapeutics Inc (TENX), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -22.62. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 155.06.
Currently, EBITDA for the company is -8.23 million with net debt to EBITDA at 4.67. When we switch over and look at the enterprise to sales, we see a ratio of -875.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.12.
Conclusion
To sum up, Tenax Therapeutics Inc (TENX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
